HAP Trading’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-100,000
Closed -$12.5K 1161
2023
Q4
$12.5K Buy
+100,000
New +$1.99M ﹤0.01% 669
2023
Q1
Sell
-10,100
Closed -$3K 1763
2022
Q4
$3K Buy
+10,100
New +$54.8K ﹤0.01% 1328
2022
Q3
Sell
-19,500
Closed -$7K 2174
2022
Q2
$7K Sell
19,500
-3,300
-14% -$14.3K ﹤0.01% 1572
2022
Q1
$11K Buy
22,800
+900
+4% +$4.98K ﹤0.01% 1768
2021
Q4
$19K Buy
+21,900
New +$136K ﹤0.01% 1831
2021
Q3
Sell
-18,200
Closed -$1K 2850
2021
Q2
$1K Buy
+18,200
New +$127K ﹤0.01% 2295
2021
Q1
Sell
-12,600
Closed -$11K 2686
2020
Q4
$11K Sell
12,600
-1,700
-12% -$9.91K ﹤0.01% 1890
2020
Q3
$2K Buy
+14,300
New +$57.7K ﹤0.01% 1525
2020
Q1
Sell
-10,900
Closed -$10K 1578
2019
Q4
$10K Buy
+10,900
New +$37K ﹤0.01% 1010
2019
Q3
Sell
-193,100
Closed -$1K 1520
2019
Q2
$1K Sell
193,100
-15,300
-7% -$36.2K ﹤0.01% 1085
2019
Q1
$5K Buy
+208,400
New +$903K ﹤0.01% 1012
2018
Q2
Sell
-90,400
Closed -$17K 1170
2018
Q1
$17K Buy
+90,400
New +$893K ﹤0.01% 786
2016
Q1
Sell
-50,200
Closed -$9K 1114
2015
Q4
$9K Sell
50,200
-100
-0.2% -$1.23K ﹤0.01% 800
2015
Q3
$29K Sell
50,300
-21,000
-29% -$307K ﹤0.01% 777
2015
Q2
$258K Buy
71,300
+39,300
+123% +$432K 0.02% 435
2015
Q1
$60K Buy
+32,000
New +$232K ﹤0.01% 601

Other funds holding IMGN

HAP Trading's IMGN Position: Q3 2023 in Review

HAP Trading sold out of Immunogen Inc (IMGN) in Q3 2023, closing a stake of 17,995 shares — an estimated $340K sold.

HAP Trading first reported a position in IMGN in Q2 2023 and held it in 1 quarter. The position peaked at $340K in Q2 2023. 275 funds tracked by Wall St. Rank hold IMGN as of Q3 2023.

  • HAP Trading reported no remaining Immunogen Inc position as of Q3 2023 after selling out during the quarter.
  • HAP Trading sold 17,995 Immunogen Inc shares in Q3 2023, an estimated $340K.
  • HAP Trading first reported a position in Immunogen Inc in Q2 2023 and held it in 1 quarter.
  • HAP Trading's Immunogen Inc position peaked at $340K in Q2 2023.
  • 275 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2023.

Based on HAP Trading's 13F filing for Q3 2023, filed 9 Nov 2023.